Portfolio Update

Finsbury Emerging Biotechnology Tst
05 July 2006



                                                                     5 July 2006





                            FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC
                                        (the "Company")
                               QUARTERLY STATEMENT OF INVESTMENTS


In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:



  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                       Value of Investment at       % of Total
                                                                                             Portfolio  Assets
                                                                        30 June 2006
AMGEN COM USD0.0001                                                       6,877,267                9.71
GENENTECH INC COM STK USD0.02 NPV                                         5,130,329                7.25
GENZYME CORP GENERAL DIVISION COM USD0.01                                 4,489,092                6.34





  • The ten largest investments held by the Company comprise the following:


Company Name                                                       Value of Investment at       % of Total
                                                                                             Portfolio Assets
                                                                 30 June 2006

AMGEN COM USD0.0001                                                       6,877,267                9.71
GENENTECH INC COM STK USD0.02 NPV                                         5,130,329                7.25
GENZYME CORP GENERAL DIVISION COM USD0.01                                 4,489,092                6.34
MEDIMMUNE INC COM USD0.01                                                 3,296,748                4.66
VERTEX PHARMACEUTICALS COM USD0.01                                        3,175,691                4.48
ENDO PHARMACEUTICALS USD0.01                                              2,870,850                4.05
GEN-PROBE INC USD0.0001                                                   2,655,878                3.75
OSI PHARMACEUTICALS COM STK US$0.01                                       2,566,159                3.62
AMYLIN PHARMACEUTICALS USD0.001                                           2,482,447                3.51
BIOMARIN PHARMACEUTICAL COM STK USD0.001                                  2,385,223                3.37







                                    - ENDS -



For further information please contact:

Tracey Lago, Senior Company Secretary

Close Finsbury Asset Management Limited

Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange